Sort   by:  
 Page size 
UnknownEarly inflammatory markers as prognostic indicators following allogeneic stem cell transplantation.
Not available
S-EPMC10791949 | biostudies-literature
UnknownLymphopenia-induced lymphoproliferation drives activation of naive T cells and expansion of regulatory populations.
Not available
S-EPMC7907823 | biostudies-literature
UnknownMixed chimerism established by hematopoietic stem cell transplantation is maintained by host and donor T regulatory cells.
Not available
S-EPMC6418492 | biostudies-literature
UnknownUnique features and clinical importance of acute alloreactive immune responses.
Not available
S-EPMC6012511 | biostudies-literature
UnknownCost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial.
Not available
S-EPMC5893943 | biostudies-literature
UnknownDimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10831058 | biostudies-literature
UnknownAzithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownBaricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998 | biostudies-literature
UnknownConvalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538 | biostudies-literature
Sort   by:  
 Page size